Dr Reddys Laboratories (RDY) EBT Margin Growth (1y) (2010 - 2021)

Dr Reddys Laboratories (RDY) EBT Margin Growth (1y) (2010 - 2021) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 342.00
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -166.00
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -5,404.00
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1,258.00
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 8,812.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2,773.00
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 132.00
10 Dr Reddys Laboratories 9.82 Bn 9.66 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2021 442.00
Mar 31, 2021 -488.00
Sep 30, 2020 -2,386.00
Jun 30, 2020 169.00
Mar 31, 2020 -209.00
Sep 30, 2019 -189.00
Jun 30, 2019 63.00
Mar 31, 2019 861.00
Dec 31, 2018 397.00
Sep 30, 2018 -82.00
Dec 31, 2017 220.00
Sep 30, 2017 -328.00
Dec 31, 2016 -695.00
Sep 30, 2016 -169.00
Dec 31, 2015 -21.00
Sep 30, 2015 -175.00
Dec 31, 2014 -697.00
Sep 30, 2014 -207.00
Mar 31, 2014 2,023.00
Dec 31, 2013 -90.00